US Stock MarketDetailed Quotes

CytoMed Therapeutics (GDTC)

Watchlist
  • 0.9501
  • -0.1088-10.27%
Close Jan 22 16:00 ET
11.15MMarket Cap-3.80P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CytoMed Therapeutics (GDTC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Total revenue
69.5K
0
0
0
0
Operating revenue
--69.5K
--0
--0
--0
--0
Cost of revenue
17.12K
0
0
Gross profit
52.38K
0
0
Operating expense
-17.17%3.18M
106.99%3.84M
7.43%1.86M
37.57%1.73M
1.26M
Selling and administrative expenses
-1.44%1.27M
223.37%1.28M
36.32%397.11K
47.87%291.32K
--197.01K
-Selling and marketing expense
-28.60%23.78K
--33.31K
--0
-59.87%2.48K
--6.18K
-General and administrative expense
-0.71%1.24M
214.98%1.25M
37.49%397.11K
51.36%288.84K
--190.83K
Research and development costs
20.12%1.91M
4.40%1.59M
39.62%1.52M
5.06%1.09M
--1.04M
Depreciation amortization depletion
17.63%122.4K
-6.88%104.05K
10.38%111.75K
16.86%101.23K
--86.63K
-Depreciation and amortization
17.63%122.4K
-6.88%104.05K
10.38%111.75K
16.86%101.23K
--86.63K
Other taxes
26.29%8.41K
-5.45%6.66K
72.63%7.05K
17.17%4.08K
--3.48K
Other operating expenses
-114.34%-123.11K
571.33%858.3K
-175.58%-182.1K
449.36%240.93K
---68.96K
Operating profit
18.54%-3.13M
-106.99%-3.84M
-7.43%-1.86M
-37.57%-1.73M
-1.26M
Net non-operating interest income expense
26.84%297.36K
290.48%234.44K
-7.65%-123.08K
-8.35%-114.33K
-105.52K
Non-operating interest income
11.18%317.67K
13,525.13%285.72K
-37.76%2.1K
--3.37K
--0
Non-operating interest expense
-60.39%20.31K
-59.03%51.28K
6.35%125.18K
11.54%117.7K
--105.52K
Other net income (expense)
159.40%311.31K
54.43%-524.11K
-449.29%-1.15M
63.51%-209.39K
-573.86K
Gain on sale of security
175.49%297.55K
-1,391.77%-394.16K
-178.68%-26.42K
-2,089.61%-9.48K
---433
Earnings from equity interest
144.12%13.77K
7.00%-31.2K
84.22%-33.55K
---212.58K
--0
Special income (charges)
--0
--0
--280
--0
--0
-Gain on sale of property,plant,equipment
--0
--0
--280
--0
--0
Other non- operating income (expenses)
----
90.94%-98.75K
-8,709.51%-1.09M
102.21%12.67K
---573.42K
Income before tax
38.98%-2.52M
-32.04%-4.13M
-52.53%-3.13M
-6.01%-2.05M
-1.94M
Income tax
0
-60.18%653
1.64K
0
0
Net income
38.98%-2.52M
-31.99%-4.13M
-52.61%-3.13M
-6.01%-2.05M
-1.94M
Net income continuous Operations
38.98%-2.52M
-31.99%-4.13M
-52.61%-3.13M
-6.01%-2.05M
---1.94M
Minority interest income
-1,784.31%-5.16K
-12.76%-274
3.95%-243
-36.02%-253
-186
Net income attributable to the parent company
39.11%-2.52M
-31.99%-4.13M
-52.62%-3.13M
-6.00%-2.05M
-1.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
39.11%-2.52M
-31.99%-4.13M
-52.62%-3.13M
-6.00%-2.05M
-1.94M
Basic earnings per share
43.59%-0.22
-36.26%-0.39
-52.62%-0.2862
-6.00%-0.1875
-0.1769
Diluted earnings per share
43.59%-0.22
-36.26%-0.39
-52.62%-0.2862
-6.00%-0.1875
-0.1769
Dividend per share
Currency Unit
SGD
SGD
SGD
SGD
SGD
Audit Opinions
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
--
--
(FY)Dec 31, 2024(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020
Total revenue 69.5K0000
Operating revenue --69.5K--0--0--0--0
Cost of revenue 17.12K00
Gross profit 52.38K00
Operating expense -17.17%3.18M106.99%3.84M7.43%1.86M37.57%1.73M1.26M
Selling and administrative expenses -1.44%1.27M223.37%1.28M36.32%397.11K47.87%291.32K--197.01K
-Selling and marketing expense -28.60%23.78K--33.31K--0-59.87%2.48K--6.18K
-General and administrative expense -0.71%1.24M214.98%1.25M37.49%397.11K51.36%288.84K--190.83K
Research and development costs 20.12%1.91M4.40%1.59M39.62%1.52M5.06%1.09M--1.04M
Depreciation amortization depletion 17.63%122.4K-6.88%104.05K10.38%111.75K16.86%101.23K--86.63K
-Depreciation and amortization 17.63%122.4K-6.88%104.05K10.38%111.75K16.86%101.23K--86.63K
Other taxes 26.29%8.41K-5.45%6.66K72.63%7.05K17.17%4.08K--3.48K
Other operating expenses -114.34%-123.11K571.33%858.3K-175.58%-182.1K449.36%240.93K---68.96K
Operating profit 18.54%-3.13M-106.99%-3.84M-7.43%-1.86M-37.57%-1.73M-1.26M
Net non-operating interest income expense 26.84%297.36K290.48%234.44K-7.65%-123.08K-8.35%-114.33K-105.52K
Non-operating interest income 11.18%317.67K13,525.13%285.72K-37.76%2.1K--3.37K--0
Non-operating interest expense -60.39%20.31K-59.03%51.28K6.35%125.18K11.54%117.7K--105.52K
Other net income (expense) 159.40%311.31K54.43%-524.11K-449.29%-1.15M63.51%-209.39K-573.86K
Gain on sale of security 175.49%297.55K-1,391.77%-394.16K-178.68%-26.42K-2,089.61%-9.48K---433
Earnings from equity interest 144.12%13.77K7.00%-31.2K84.22%-33.55K---212.58K--0
Special income (charges) --0--0--280--0--0
-Gain on sale of property,plant,equipment --0--0--280--0--0
Other non- operating income (expenses) ----90.94%-98.75K-8,709.51%-1.09M102.21%12.67K---573.42K
Income before tax 38.98%-2.52M-32.04%-4.13M-52.53%-3.13M-6.01%-2.05M-1.94M
Income tax 0-60.18%6531.64K00
Net income 38.98%-2.52M-31.99%-4.13M-52.61%-3.13M-6.01%-2.05M-1.94M
Net income continuous Operations 38.98%-2.52M-31.99%-4.13M-52.61%-3.13M-6.01%-2.05M---1.94M
Minority interest income -1,784.31%-5.16K-12.76%-2743.95%-243-36.02%-253-186
Net income attributable to the parent company 39.11%-2.52M-31.99%-4.13M-52.62%-3.13M-6.00%-2.05M-1.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 39.11%-2.52M-31.99%-4.13M-52.62%-3.13M-6.00%-2.05M-1.94M
Basic earnings per share 43.59%-0.22-36.26%-0.39-52.62%-0.2862-6.00%-0.1875-0.1769
Diluted earnings per share 43.59%-0.22-36.26%-0.39-52.62%-0.2862-6.00%-0.1875-0.1769
Dividend per share
Currency Unit SGDSGDSGDSGDSGD
Audit Opinions Unqualified OpinionUnqualified OpinionUnqualified Opinion with Explanatory Notes----
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -